The Traderszone Network

Published in TZ Latest News 7 August, 2015 by The TZ Newswire Staff

What’s Behind Ophthotech’s Rapid Run Higher in July?

A chance for its clinical-stage drug Fovista to become a go-to vision therapy is sending shares higher.